Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.
William Andrew Macan net worth and biography

William Macan Biography and Net Worth

W. Andrew Macan has served as Neuronetics’ Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary since January 2020.

Prior to joining Neuronetics, Mr. Macan was Senior Vice President, General Counsel and Corporate Secretary of U.S. Silica Holdings, Inc., a Russell 2000 diversified minerals company, from October 2018 until January 2020. He served in roles of increasing responsibility with Axalta Coating Systems, LLC, from October 2013 until October 2018, most recently as General Counsel and Chief Compliance Officer, Americas, and The Chubb Corporation, from October 2003 until October 2013, including as Vice President, Corporate Counsel and Secretary for over 8 years.

Mr. Macan began his career in private practice at Ballard Spahr LLP and Dechert LLP. He earned a B.A. in Government from Franklin & Marshall College and his J.D. from Emory University School of Law with distinction and Order of the Coif.

What is William Andrew Macan's net worth?

The estimated net worth of William Andrew Macan is at least $1.96 million as of January 23rd, 2023. Mr. Macan owns 338,719 shares of Neuronetics stock worth more than $1,964,570 as of January 28th. This net worth estimate does not reflect any other assets that Mr. Macan may own. Learn More about William Andrew Macan's net worth.

How do I contact William Andrew Macan?

The corporate mailing address for Mr. Macan and other Neuronetics executives is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. Neuronetics can also be reached via phone at (610) 640-4202 and via email at [email protected] Learn More on William Andrew Macan's contact information.

Has William Andrew Macan been buying or selling shares of Neuronetics?

During the last ninety days, William Andrew Macan has sold $95,634.16 in Neuronetics stock. Most recently, William Andrew Macan sold 16,046 shares of the business's stock in a transaction on Monday, January 23rd. The shares were sold at an average price of $5.96, for a transaction totalling $95,634.16. Following the completion of the sale, the senior vice president now directly owns 338,719 shares of the company's stock, valued at $2,018,765.24. Learn More on William Andrew Macan's trading history.

Who are Neuronetics' active insiders?

Neuronetics' insider roster includes Robert Cascella (Director), Sheryl Conley (Director), Stephen Furlong (CFO), Gregory Harper (VP), William Macan (VP), Bruce Shook (Director), and Keith Sullivan (CEO). Learn More on Neuronetics' active insiders.

Are insiders buying or selling shares of Neuronetics?

In the last twelve months, Neuronetics insiders bought shares 24 times. They purchased a total of 407,045 shares worth more than $1,040,250.94. In the last twelve months, insiders at the sold shares 21 times. They sold a total of 375,977 shares worth more than $2,122,882.58. The most recent insider tranaction occured on January, 23rd when SVP William Andrew Macan sold 16,046 shares worth more than $95,634.16. Insiders at Neuronetics own 5.2% of the company. Learn More about insider trades at Neuronetics.

Information on this page was last updated on 1/23/2023.

William Andrew Macan Insider Trading History at Neuronetics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/23/2023Sell16,046$5.96$95,634.16338,719View SEC Filing Icon  
10/10/2022Sell76$2.82$214.32354,765View SEC Filing Icon  
10/7/2022Sell1,547$2.93$4,532.71354,841View SEC Filing Icon  
7/8/2022Sell2,746$3.60$9,885.60356,388View SEC Filing Icon  
2/7/2022Sell4,716$3.26$15,374.16View SEC Filing Icon  
1/24/2022Sell11,562$3.52$40,698.24View SEC Filing Icon  
7/8/2021Sell2,591$14.61$37,854.51210,491View SEC Filing Icon  
3/10/2020Buy5,000$2.00$10,000.00182,399View SEC Filing Icon  
See Full Table

William Andrew Macan Buying and Selling Activity at Neuronetics

This chart shows William Andrew Macan's buying and selling at Neuronetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neuronetics Company Overview

Neuronetics logo
Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
Read More

Today's Range

Now: $5.80
Low: $5.77
High: $5.98

50 Day Range

MA: $6.16
Low: $5.20
High: $6.87

2 Week Range

Now: $5.80
Low: $1.98
High: $6.95


144,819 shs

Average Volume

206,135 shs

Market Capitalization

$157.88 million

P/E Ratio


Dividend Yield



Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.